Sodium 5,5'-((3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)methylene)bis(2-hydroxybenzoate)

Catalog No. :
ACXWMS006
CAS No. :
13186-45-3
Molecular Formula :
C22H11Na3O9
Molecular Weight :
488.29

IUPAC Name:sodium 5,5'-((3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)methylene)bis(2-hydroxybenzoate)

Sodium 5,5'-((3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)methylene)bis(2-hydroxybenzoate) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 5,5'-((3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)methylene)bis(2-hydroxybenzoate)
IUPAC Namesodium 5,5'-((3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)methylene)bis(2-hydroxybenzoate)
MDL No.MFCD00044252
Molecular FormulaC22H11Na3O9
Molecular Weight488.29
SMILESOC1=CC=C(C(C2=CC(C([O-])=O)=C(O)C=C2)=C(C=C3)C=C(C([O-])=O)C3=O)C=C1C([O-])=O.[Na+].[Na+].[Na+]
InChI KeyXWOVYFGIWQEHHR-UHFFFAOYSA-K
SynonymAURINTRICARBOXYLIC ACID TRISODIUM SALT;aurintricaboxylicacidtrisodiumsalt;c.i.mordantviolet39;c.i.mordantviolet39,trisodiumsalt;chromevioletg;mordantviolet39;trisodium 5,5-(3-carboxylato-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylate);5,5'-[[4-Oxo-3-(sodiooxycarbonyl)-2,5-cyclohexadien-1-ylidene]methylene]bis[2-hydroxybenzoic acid sodium] salt
CAS No.13186-45-3

Synthetic Route by SureRoute

1. ACXWMS006 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXWMS006 route product structure diagram
    ACXWMS00613186-45-3
Inquiry

2. ACXWMS006 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXWMS006 route product structure diagram
    ACXWMS00613186-45-3
Inquiry

Comments (0)